Account Info
Log Out
English
Back
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record delete
    Quotes All >
      News All >
        Log in to access Online Inquiry

        Pfizer reports strong Q4 earnings with the FY23 guidance

        Pfizer Inc. (PFE) on Tuesday reported its latest earnings results. The Earnings Highlights are below: ▶️ Full-year 2022 revenues of $100.3 ... Show More
        Pfizer Inc. (PFE) on Tuesday reported its latest earnings results. The Earnings Highlights are below:
        ▶️ Full-year 2022 revenues of $100.3 billion, an all-time high for Pfizer, reflecting 30% operational growth.
        ▶️ Strong fourth-quarter 2022 revenues of $24.3 billion, reflecting 13% operational growth.
        ▶️ Full-year 2022 reported diluted EPS of $5.47, up 42% year-over-year, and adjusted diluted eps of $6.58, up 62% year-over-year, both of which represent all-time highs for Pfizer.
        ▶️ Fourth-quarter 2022 reported diluted EPS of $0.87, up 48% year-over-year, and adjusted diluted EPS of $1.14, up 45% year-over-year.
        ▶️ Provides full-year 2023 revenue guidance of $67.0 to $71.0 billion and adjusted diluted EPS guidance of $3.25 to $3.45.
        1. Do you feel satisfied with the latest earnings results?
        2. What's your opinion or analysis about the company?
        Views
        27K
        Posts
        4
        Join topic
        New
        Hot
        Related Stocks
        • PFE
          Pfizer
          32.690
          -0.49%
        • MRNA
          Moderna
          99.990
          -0.24%
        • BNTX
          BioNTech
          104.640
          -1.68%
        • ARKG
          ARK Genomic Revolution ETF
          27.910
          -1.13%
        • CARA
          Cara Therapeutics
          1.670
          -2.91%